SUPERLUMINAL MEDICINES: ANNOUNCES OVERSUBSCRIBED $60 MLN SERIES B FINANCING TO ADVANCE LEAD PROGRAM IN RARE GENETIC FORMS OF OBESITY INTO CLINIC

Reuters · 3d ago

Please log in to view news